Showing results (901-910 of 924) with videos related to
Sort By:
Pageof 93
Journal of Medicinal Chemistry|March 24, 2009
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonistsChia-Hui Lin, Yi-Hui Peng, Mohane Selvaraj Coumar, et al.Neuropharmacology|September 13, 2015
The potential of synthetic indolylquinoline derivatives for Aβ aggregation reduction by chemical chaperone activityKuo-Hsuan Chang, Ya-Jen Chiu, Shu-Ling Chen, et al.Cancer Research|June 24, 2015
Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf-DAPK Complex by Raf Inhibitor Combination TherapyYi-Ta Tsai, Mei-Jen Chuang, Shou-Hung Tang, et al.Science Signaling|February 11, 2010
ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathwayHsu-Ping Kuo, Dung-Fang Lee, Chun-Te Chen, et al.Bioorganic & Medicinal Chemistry Letters|June 25, 2019
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®John O Link, James G Taylor, Alejandra Trejo-Martin, et al.Nature Medicine|March 14, 2007
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic diseaseJean-Pyo Lee, Mylvaganam Jeyakumar, Rodolfo Gonzalez, et al.Biology|August 26, 2022
Innovative Hybrid-Alignment Annotation Method for Bioinformatics Identification and Functional Verification of a Novel Nitric Oxide Synthase in Trichomonas vaginalisHung-Che Lin, Hao-Ai Shui, Kuo-Yang Huang, et al.Gut|January 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver diseaseYu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng, et al.The Journal of Clinical Investigation|November 17, 2015
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab responseHsin-Wei Liao, Jung-Mao Hsu, Weiya Xia, et al.Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.Pageof 93